Investor Presentations

Sanofi is pleased to invite investors and analysts to participate in its R&D event being held in person at the Kimpton Hotel Eventi in New York City on Thursday, December 7, 2023 starting at 8:30am EST. 
The event will be webcasted live and available for replay on our website afterwards.

Sanofi was pleased to host investors and analysts for its Vaccines Investor Event held in person on June 29th, 2023

Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.
(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)

Sanofi was pleased to host investors and analysts for its Hemophilia Investor Event held in person at ExCel London on Wednesday, July 13, 2022. (2:00pm GMT / 15h00 CET / 9:00am EST)

Sanofi was pleased to invite investors and analysts to participate in its ESG Investor Event held in-person at the Sanofi Headquarters (54, rue La Boétie, 75008 Paris) on Tuesday, July 5, 2022. (14:00h CET / 8:00am EST)

Sanofi was pleased to host investors and analysts for its Immunology Investor Event held in person in our new Sanofi Cambridge Headquarters in Cambridge, Massachusetts. (16h00 CET / 10:00am EST)

Sanofi was pleased to invite investors and analysts to participate in a live webcast discussing tolebrutinib data presented during the ACTRIMS scientific program (February 24-26, 2022). (16h00 CET / 10:00am EST)

As part of our Social Impact Strategy embedded in our Play to Win business strategy, we are committed to integrate sustainability in our financing strategies.